Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
02/28/2013 | CA2845854A1 C-halogen bond formation |
02/28/2013 | CA2845578A1 Pyrimidine pde10 inhibitors |
02/27/2013 | EP2562174A1 Herbicidal 6-Oxo-1,6-dihydropyrimidin-5-carboxamides and 2-Oxo-1,2-dihydropyridin-3-carboxamides |
02/27/2013 | EP2562168A1 Therapeutic piperazines as PDE4 inhibitors |
02/27/2013 | EP2562167A1 5-fluoro pyrimidine derivatives as fungicides |
02/27/2013 | EP2562165A1 5-fluoro pyrimidine derivatives as fungicides |
02/27/2013 | EP2562161A1 5-fluoro pyrimidine derivatives as fungicides |
02/27/2013 | EP2562160A1 Therapeutic agent or preventive agent for urine collection disorder |
02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
02/27/2013 | EP2561871A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer |
02/27/2013 | EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors |
02/27/2013 | EP2560966A2 Multisubstituted aromatic compounds as inhibitors of thrombin |
02/27/2013 | EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors |
02/27/2013 | EP2560955A2 Novel benzamide derivatives |
02/27/2013 | EP2560953A2 Novel inhibitors |
02/27/2013 | EP2560653A1 Certain amino-pyrimidines, compositions thereof, and methods for their use |
02/27/2013 | EP2560652A2 Anti-viral compounds |
02/27/2013 | EP2560488A1 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
02/27/2013 | CN102947415A Organic electronic devices comprising a layer of a pyridine compound and a 8-hydroxyquinolinolato earth alkaline metal, or alkali metal complex |
02/27/2013 | CN102947293A Triazole-substituted anthranilic acid amides as pesticides |
02/27/2013 | CN102947292A Nitrogen containing heteroaryl compounds |
02/27/2013 | CN102947291A Prodrug of triazolone compound |
02/27/2013 | CN102947290A Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
02/27/2013 | CN102947289A Arylethynyl derivatives |
02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
02/27/2013 | CN102947275A Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
02/27/2013 | CN102947274A Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
02/27/2013 | CN102946881A Anti-viral compounds |
02/27/2013 | CN102942558A Preparation method of benzazepine derivatives |
02/27/2013 | CN102942557A Novel medicinal salt of dexlansoprazole |
02/27/2013 | CN102942556A Preparation technique of alogliptin benzoate |
02/27/2013 | CN102942529A 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound |
02/27/2013 | CN102942431A Method for separating chiral compound by using molecular sieves |
02/27/2013 | CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts |
02/27/2013 | CN102002035B Delta and epsilon crystal forms of imatinib mesylate |
02/27/2013 | CN101987843B Method for synthesizing halofuginone hydrobromide and analogues thereof |
02/27/2013 | CN101962379B Method for refining sulfonyl isoquinoline derivative |
02/27/2013 | CN101827828B 1, 2, 4 -triazole derivatives as serotonergic modulators |
02/27/2013 | CN101824033B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
02/27/2013 | CN101687851B Organic compounds |
02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
02/27/2013 | CN101511800B Triazolyl phenyl benzenesulfonamides |
02/27/2013 | CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
02/26/2013 | US8383814 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof |
02/26/2013 | US8383666 Pyrrole derivatives, preparation of same and therapeutic application thereof |
02/26/2013 | US8383660 Dibenzyl amine compounds and derivatives |
02/26/2013 | US8383651 Compounds which selectively modulate the CB2 receptor |
02/26/2013 | US8383650 Organic compounds |
02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
02/26/2013 | US8383646 Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds |
02/26/2013 | US8383642 Spiropiperidine compounds |
02/26/2013 | US8383638 Aminobenzoquinazolinone M1 receptor positive allosteric modulators |
02/26/2013 | US8383637 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
02/26/2013 | US8383629 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
02/26/2013 | US8383628 Pyridyl derivatives and their use as therapeutic agents |
02/26/2013 | US8383616 Aryl isoxazole compounds with antitumoural activities |
02/26/2013 | CA2608468C Tri-, tetra-substituted-3-aminopyrrolidine derivative |
02/26/2013 | CA2572544C Modified pyrimidine glucocorticoid receptor modulators |
02/26/2013 | CA2571527C Piperazinediones as oxytocin receptor antagonists |
02/26/2013 | CA2523426C Aza spiro alkane derivatives as inhibitors of metalloproteases |
02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
02/21/2013 | WO2013024394A1 Novel reference markers of dabigatran etexilate |
02/21/2013 | WO2013024384A1 Improved process for preparation of dabigatran etexilate and its novel intermediate |
02/21/2013 | WO2013024358A2 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors |
02/21/2013 | WO2013024171A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests |
02/21/2013 | WO2013024170A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests |
02/21/2013 | WO2013024078A1 Inhibitors of bruton's tyrosine kinase |
02/21/2013 | WO2013024010A1 N-thio-anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013024009A1 N-thio-anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013024008A1 Aniline type compounds |
02/21/2013 | WO2013024007A1 Process for preparing n-substituted 1h-pyrazole-5-carbonylchloride compounds |
02/21/2013 | WO2013024006A1 Anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013024005A1 Anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013024004A1 N-thio-anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013024003A1 N-thio-anthranilamide compounds and their use as pesticides |
02/21/2013 | WO2013023795A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
02/21/2013 | WO2012149186A9 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
02/21/2013 | WO2012026897A9 A process for the preparation of imatinib base |
02/21/2013 | WO2012022120A8 Dihydropyrazole compounds |
02/21/2013 | US20130046095 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
02/21/2013 | US20130045994 Pyridine derivative |
02/21/2013 | US20130045992 Compositions and Methods for Enhancing Proteasome Activity |
02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
02/21/2013 | US20130045977 TGF-beta SIGNAL TRANSDUCTION INHIBITOR |
02/21/2013 | US20130045976 Isoindoline compounds and methods of their use |
02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
02/21/2013 | US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors |
02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
02/21/2013 | US20130045962 Peptide deformylase inhibitors |
02/21/2013 | US20130045955 Novel compounds |
02/21/2013 | US20130043460 Carbazole serial compounds |
02/21/2013 | US20130043137 Novel compound and use thereof |
02/21/2013 | DE102010023959B4 Neue Verbindungen als Liganden für Übergangsmetallkomplexe und daraus hergestellte Materialien, sowie Verwendung dazu New compounds as ligands for transition metal complexes and derived materials, and use this |
02/21/2013 | CA2845477A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
02/21/2013 | CA2845284A1 Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors |
02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |